MEDITE Cancer Diagnostics, Inc. specializes in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions. The Company has a well developed infrastructure with over employees in four countries, a distribution network to about countries worldwide, a well known and established brand name and a wide range of products for anatomic pathology, histology and cytology laboratories.
Quote | MEDITE Cancer Diagnostics Inc (OTCMKTS:MDIT)
Last: | $0.0001 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0001 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | MEDITE Cancer Diagnostics Inc (OTCMKTS:MDIT)
Message Board Posts | MEDITE Cancer Diagnostics Inc (OTCMKTS:MDIT)
Subject | By | Source | When |
---|---|---|---|
Their address is a $UPS store. Address | IslandTrader | investorshub | 11/07/2018 4:44:08 PM |
.02 is coming true very soon! | IslandTrader | investorshub | 05/13/2017 5:02:25 AM |
I wonder how many more friends are in | IslandTrader | investorshub | 05/13/2017 4:53:25 AM |
IslandTrader | investorshub | 05/13/2017 4:53:24 AM | |
Link to article: http://www.businesswire.com/news/home/20150909006062/en/Invest | IslandTrader | investorshub | 09/09/2015 7:17:08 PM |